SHMT2 and acute myeloid leukemia: Collectively, the down-regulation of SRSF7 expression results in the retention of intron 2 within the SHMT2 pre-mRNA as well as the dysregulation of other pathways, leading to cell death and cell cycle arrest, thereby inhibiting AML development (Fig. S11).